GRFS

NASDAQ · Equity

Grifols SA ADR

US Healthcare Drug Manufacturers - General

Latest week
29 May 2026
Close
7.850000
Fair value
8.404785
Expectation
Positive 56.04%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
7.85
12-Week Change
0.51%
Trend Signal
Inactive
Expectation
Positive 56.04%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-29.60
Market Dynamics
-0.72

Over the latest 12 completed weeks ending 2026-05-29, GRFS rose 0.51%, moving from 7.81 to 7.85. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -29.60 and has softened across the 12-week window. Market Dynamics is -0.72 on the latest week. Expectation is positive at 56.04%.